South University (SU) is proud to highlight a powerful example of its mission in action, as faculty from the SU Tampa ...

After a data monitoring committee saw increased risk of secondary blood cancers in the SYPHONY-1 trial, the firm will stop selling the drug for follicular lymphoma and sarcoma.

Inform future clinical development plans, further establishing elraglusib as a potential backbone therapy in ...

After an independent data monitoring committee raised safety flags in a clinical trial, Ipsen is shutting down the cancer med Tazverik, which it picked up through its acquisition of Epizyme less than ...

The winter sports world is still buzzing from the recently concluded Olympic Games. Over the last few weeks, we watched Team USA deliver outstanding performances and display the kind of genuine ...